Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 0 0 0 135
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 0 0 1 48
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 0 0 1 120
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 1 1 2 153 3 5 11 390
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 0 1 5 675
Lies have long legs. Cheating, public scrutiny and loyalty in teams 0 0 0 43 1 1 4 159
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 1 3 22 1 3 15 47
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 16 16 0 1 29 29
Optimizing Tax Administration Policies with Machine Learning 0 0 5 265 0 0 14 689
R&D and market size: who benefits from orphan drug regulation? 0 0 1 76 0 3 5 197
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 1 2 2 24 1 2 4 66
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 3 26 0 1 5 130
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 1 89 0 0 5 128
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 1 2 3 90
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 1 72 0 1 6 120
What exactly is public in a public good game? A lab-in-the-field experiment 0 1 3 156 0 3 14 363
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 2 3 95 1 6 12 153
Total Working Papers 2 7 40 1,461 8 29 134 3,539

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 2 17 0 0 4 87
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 1 1 4 34
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 0 0 0 15
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 0 0 1 22
Machine learning and the optimization of prediction-based policies 0 1 1 5 3 6 7 15
R&D and market size: Who benefits from orphan drug legislation? 0 0 0 4 0 1 4 30
R&D investments, financing constraints, exporting and productivity 0 0 2 57 0 2 7 166
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 1 5 19 1 3 11 113
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 0 0 0 2 0 0 3 7
The impact of managed entry agreements on pharmaceutical prices 0 1 2 15 1 3 7 79
The impact of social pressure on tax compliance: A field experiment 0 1 2 26 0 1 10 127
When the two ends meet: an experiment on cooperation and social capital 0 0 0 5 0 1 1 27
Total Journal Articles 0 4 14 163 6 18 59 722

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2025-07-04